相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee
Gabriella Giancane et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2019)
Pediatric Rheumatology Collaborative Study Group - over four decades of pivotal clinical drug research in pediatric rheumatology
Hermine I. Brunner et al.
PEDIATRIC RHEUMATOLOGY (2018)
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Results From a Phase III Open-Label Study
Hermine Brunner et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries
Joost Swart et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
Hermine I. Brunner et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Remarkable Pharmacokinetics of Monoclonal Antibodies: A Quest for an Explanation
Joannes A. A. Reijers et al.
CLINICAL PHARMACOKINETICS (2017)
Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan
Shunsuke Mori et al.
PLOS ONE (2017)
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting
Vivianne Malmstrom et al.
NATURE REVIEWS IMMUNOLOGY (2017)
No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysis
Claire Baradat et al.
RMD OPEN (2017)
Infection Risk and Safety of Corticosteroid Use
Jameel Youssef et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance
K. L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Advances in the treatment of polyarticular juvenile idiopathic arthritis
Kate Webb et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy
Huifeng Yun et al.
ARTHRITIS CARE & RESEARCH (2015)
Biologic-Associated Infections in Pediatric Rheumatology
Gerd Horneff
CURRENT RHEUMATOLOGY REPORTS (2015)
Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years
Daniel J. Lovell et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting
Maarit Tarkiainen et al.
RHEUMATOLOGY (2015)
Drug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis - focus on subcutaneous tocilizumab
Yasuharu Nakashima et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Development and Validation of a Risk Score for Serious Infection in Patients With Rheumatoid Arthritis
Cynthia S. Crowson et al.
ARTHRITIS AND RHEUMATISM (2012)
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
Timothy Beukelman et al.
ARTHRITIS AND RHEUMATISM (2012)
The origins, function, and regulation of T follicular helper cells
Cindy S. Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Networking in paediatrics: the example of the Paediatric Rheumatology International Trials Organisation (PRINTO)
Nicolino Ruperto et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2011)
Safety of biologic therapy in rheumatoid arthritis
Robert S. Woodrick et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Timothy Beukelman et al.
ARTHRITIS CARE & RESEARCH (2011)
Long-Term Safety and Efficacy of Abatacept in Children With Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2010)
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis
Diane Lacaille et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Abatacept in children with juvenile idiopathic arthritis:: a randomised, double-blind, placebo-controlled withdrawal trial
Nicolino Ruperto et al.
LANCET (2008)
Abatacept treatment improves health-related quality of life, pain, and sleep quality in juvenile idiopathic arthritis patients
N Ruperto et al.
Pediatric Rheumatology (2008)
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
M. C. Genovese et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Juvenile idiopathic arthritis
Angelo Ravelli et al.
LANCET (2007)
Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis
E Silverman et al.
ARTHRITIS AND RHEUMATISM (2005)
The efficacy and safety of leflunomide in patients with active rheumatoid arthritis -: A five-year followup study
JR Kalden et al.
ARTHRITIS AND RHEUMATISM (2003)
Predictors of infection in rheumatoid arthritis
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
分享论文
